Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
p decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
19 p » 19 _ (Expand Search)
Showing 141 - 160 results of 120,461 for search '(( 19 p decrease ) OR ( 5 ((((ng decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.73s Refine Results
  1. 141
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 142
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 143
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 144
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 145
    Long-term anti-nucleocapsid response by baseline patient characteristics.

    Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 146
    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.

    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 147
    Baseline patient characteristics across neutralizing monoclonal antibody trials.

    Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 148
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 149
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 150
    Overview of the six original ACTIV-3/TICO trials.

    Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 151
    IL-2 accumulation decreases in response to viable <i>P. gingivalis</i> and its derived supernatant.

    IL-2 accumulation decreases in response to viable <i>P. gingivalis</i> and its derived supernatant. by Hazem Khalaf (308041)

    Published 2013
    Save to List
    Saved in:
  12. 152
    Lack of SPI-14 decreased <i>S</i>. Typhimurium virulence in mice by affecting intestinal invasion.

    Lack of SPI-14 decreased <i>S</i>. Typhimurium virulence in mice by affecting intestinal invasion. by Lingyan Jiang (4063771)

    Published 2017
    Save to List
    Saved in:
  13. 153
    LGP2 overexpression decreases the transcript levels of the IFN signaling and proinflammatory cytokines during ZIKV infection.

    LGP2 overexpression decreases the transcript levels of the IFN signaling and proinflammatory cytokines during ZIKV infection. by Zhongyuan Tan (5779016)

    Published 2023
    Save to List
    Saved in:
  14. 154
    Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em><sub>g</sub> levels

    Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em><sub>g</sub> levels by Dieter Gerten (557088)

    Published 2013
    “…<p><strong>Figure 2.</strong> Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em><sub>g</sub> levels. …”
    Save to List
    Saved in:
  15. 155
    Maximum glomerular filtration rate decrease within 7 days after renal surgery.

    Maximum glomerular filtration rate decrease within 7 days after renal surgery. by Ana Stevanovic (454569)

    Published 2017
    Save to List
    Saved in:
  16. 156
    mFIZZ1′ and mFIZZ1 decreased the IL-13 and IL-5 secretion of splenocytes.

    mFIZZ1′ and mFIZZ1 decreased the IL-13 and IL-5 secretion of splenocytes. by Wael Gad (285901)

    Published 2013
    “…(<b>A</b>) Recombinant mFIZZ1′ and mFIZZ1 co-expressed with hQSOX1b significantly decreased the IL-5 secretion compared to the proteins expressed alone. …”
    Save to List
    Saved in:
  17. 157
    24 h fasting decreases mARC protein levels and <i>N</i>-reductive activity in mice.

    24 h fasting decreases mARC protein levels and <i>N</i>-reductive activity in mice. by Heyka H. Jakobs (619421)

    Published 2014
    Save to List
    Saved in:
  18. 158
    Adjusted prevalences (aP) by age, sex and altitude.

    Adjusted prevalences (aP) by age, sex and altitude. by Juan Alonso Leon-Abarca (8308005)

    Published 2021
    Save to List
    Saved in:
  19. 159
    Decrease of full-length tRNAs under oxidative stress.

    Decrease of full-length tRNAs under oxidative stress. by Jiayong Zhong (757895)

    Published 2015
    “…<p>The tRNAs are displayed in alphabetical order and named according to their amino acids and anticodons. (A) Decreased tRNA levels following 15 min of H<sub>2</sub>O<sub>2</sub>-induced oxidative stress, relative to tRNA levels observed under normal conditions. …”
    Save to List
    Saved in:
  20. 160
    Early increase and later decrease in GSK-3β activity.

    Early increase and later decrease in GSK-3β activity. by Arie J. Hoogendijk (353624)

    Published 2013
    Save to List
    Saved in:

Search Tools: